Problem statement: Answer the multiple-choice question.
Query: Which drug exhibits a 12.226% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
a OCCC1CN(Cc2cccs2)CCN1Cc1ccccc1
b Cc1cc(C)c(C(N)=O)c(Nc2cccc(Cl)c2C)n1
c Cc1cc([N+](=O)[O-])nn1CCCC(=O)Nc1cccnc1Cl
d CC(CNS(=O)(=O)c1cc(Cl)ccc1Cl)CN(C)C
Answer: d. CC(CNS(=O)(=O)c1cc(Cl)ccc1Cl)CN(C)C
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(CNS(=O)(=O)c1cc(Cl)ccc1Cl)CN(C)C
CC(CNS(=O)(=O)c1cc(Cl)ccc1Cl)CN(C)C
2,5-dichloro-N-[3-(dimethylamino)-2-methylpropyl]benzenesulfonamide